Thursday's Winners & Losers: RIM

BlackBerry maker RIM(RIMM Quote) gained $7.06, or 6.1%, to $122.80 after the company blew past analysts' estimates for the fourth quarter and guided higher than expectations for the current quarter. Net income for the fourth quarter jumped 120% to $412.5 million, or 72 cents a share, while revenue rose 102% to $1.88 billion.

Analysts polled by Thomson Financial were expecting revenue of $1.85 billion and earnings of 70 cents a share. For the current quarter, RIM forecast revenue in the range of $2.23 billion to $2.3 billion, and EPS in the range of 82 cents to 86 cents -- higher than analysts' consensus of $2 billion in sales and EPS of 75 cents.

Meanwhile, investors granted Schering-Plough (SGP Quote) shares a bit of relief, reacting positively to a $1.5 billion cost-cutting plan. Shares rose $1.49, or 10.8%, to $15.35.

Shares of Syntax-Brillian (BRLC Quote), a Tempe, Ariz.-based maker of high-definition TVs, jumped 16% to $1.23. The company announced a partnership with Compal Electronics, under which Compal will fill an initial manufacturing order of 300,000 televisions in its Chinese facility. Syntax-Brillian CEO James Li said that the move was key to the company's cost-reduction and cash flow-improvement efforts.

Access Integrated Tech (AIXD Quote) climbed 18.5% to $3.85. The Morristown, N.J.-based provider of integrated solutions for digital cinema announced it had extended the employment contract of CEO A. Dale Mayo through March 31, 2011.

Semiconductor company MEMC Electronic Materials(WFR Quote) fell $2.61, or 3.4%, to $73.83 after the company lowered its first-quarter revenue outlook. MEMC said it expects revenue of about $500 million and gross margin of 52%, compared with its earlier forecast of $560 million and gross margin of 54.2%.

Elsewhere, AngioDynamics (ANGO Quote) rose $1.26, or 11%, to $12.81 Thursday after earnings and settlement news.

The company said it reached an agreement with Diomed to resolve a patent infringement lawsuit dating back to January 2004. As a result, AngioDynamics said it decreased its litigation provision and also recorded a net after-tax gain of $2 million, and 8 cents a share in its third quarter.

For the quarter -- including the settlement -- the company earned $4.8 million, or 20 cents a share. Analysts surveyed by Thomson Financial had predicted 12 cents a share.